Welcome to the working week. We hope your weekend was pleasant, despite a spot of rain that continues to linger over the Pharmalot corporate campus and our general vicinity. Nonetheless, our spirits are sunny as we ready ourselves for another day. As usual, we are armed with a cup of stimulation and a grab bag of interesting items. Dig in and have a good one...
Novartis Buys Alnylam Shares (Associated Press)
Dendreon Stock Will Rise On FDA Approval (TheStreet)
European Medicines Agency Is Overwhelmed With Work (PharmaTimes)
Merck & Nycomed To Market COPD Drug (MarketWatch)
North Dakokta AG Questions Import Bill (KXNET.com)
Merck Says Health Care Reform To Cost $320M (Associated Press)